Your savings and support resource for Sogroya®
You’ve come to the right place to find coverage and cost information, as well as a savings offer that may help lower your out-of-pocket costs.
Interested in personalized support and information during therapy? NovoCare® offers both with a dedicated Case Manager. Learn how the program works below.
Your savings and support resource for Sogroya®
You’ve come to the right place to find coverage and cost information, as well as a savings offer that may help lower your out-of-pocket costs.
Interested in personalized support and information during therapy? NovoCare® offers both with a dedicated Case Manager. Learn how the program works below.
Check your coverage for Sogroya®
Once therapy is recommended by your health care provider, the office can verify if you are covered for Novo Nordisk's treatment—in less than 4 hours. Once your information is submitted, NovoCare® will provide treatment coverage confirmation, as well as any deductible, copay, and/or coinsurance assistance that may apply. If no coverage is available for the therapy you were prescribed, NovoCare® may supply the names of other therapies that are covered.
Call 1-888-668-6444 to see if you’re covered.
The insurance process, simplified
How it works
NovoCare® can help you navigate the insurance process by:
- Working with your insurance company to learn if the prescribed drug is covered
- Sharing Prior Authorization forms and submission process information with the health care provider
- Following up to find out whether or not coverage was provided
NovoCare® also assists with next steps—depending on the outcome.
If approved
If insurance coverage is approved, NovoCare® will:
- Coordinate relevant information between the health care provider and a specialty pharmacy that carries the prescribed growth hormone (GH) therapy
- Determine if the patient is eligible to save money on prescriptions through the NovoCare® Savings Offer
If denied
If insurance coverage is denied, NovoCare® will:
- Provide eligible families with information about the multi-step appeal processa
- Determine whether the patient is eligible to enroll in the Patient Assistance Program for their medicine
aAppeal support is available for patients prescribed a Novo Nordisk product for a diagnosis that is an FDA-approved indication.
Save on your medication
If you have commercial insurance, such as insurance you receive through an employer or purchase yourself, you may be eligible for savings on your Sogroya® medicine.
Request copay savings today.
Our commitment to affordability
If you have commercial insurance
Fill in the gaps with JumpStart™
If you’re experiencing a gap or delay in insurance coverage, you may be eligible for JumpStart™—a program that provides a limited supply of free Sogroya® to those who qualify.
Call 1-888-668-6444 to see if you qualify.
If you have no insurance
Get free medication through the Patient Assistance Program (PAP)
Lack of insurance coverage or limited financial means shouldn’t prevent you from getting the treatment you need. If you don’t have adequate insurance coverage, you may qualify to receive Sogroya® free of charge.
Request a starter kit
The Patient Starter Kit contains support materials to help patients initiate therapy.
Provided exclusively through NovoCare® upon request.
To request a starter kit, call 1‑888‑668‑6444.
NovoCare® provides personalized support and information during therapy
A dedicated Case Manager is ready to help. Call NovoCare® at 1‑888‑688‑6444 Monday‑Friday, 8:00 am‑8:00 pm ET.
How the NovoCare® program works:
01
Enrollment
An enrollment form, containing a prescription, will be sent from your health care provider’s office to NovoCare®.
02
Welcome call
Once the prescription is received by NovoCare®, a dedicated Case Manager will reach out to you.
03
Insurance coverage and costs
The next step is to provide you with information about your insurance coverage and potential out-of-pocket costs. You can ask us about the Savings Offer (for eligible patients).
04
Specialty pharmacy shipment
Once the insurance company approves the prescription, NovoCare® will send it to a specialty pharmacy. They will reach out to you to schedule the shipment. A prompt call back to the pharmacy will help ensure a timely shipment of your product. You’ll also receive your starter kit, if requested.
05
Device training
As you prepare for your first shipment, your Case Manager will reach out to you to provide you with the opportunity to schedule an in-person or virtual training to ensure you’re comfortable with the pen and injection process.
06
Follow-up
NovoCare® will continue to be available to assist you with product questions and support you with therapy.
Call NovoCare® at 1‑888‑688‑6444 Monday‑Friday, 8:00 am‑8:00 pm ET.
Important Safety Information
Do not use Sogroya® if:
- you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
- you have cancer or other tumors
- you are allergic to somapacitan-beco or any of the ingredients in Sogroya®
- your healthcare provider tells you that you have certain types of eye problems caused by diabetes
- you are a child with closed bone growth plates
- you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)
What is Sogroya®?
- Sogroya® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body.
- It is given by injection under the skin (subcutaneous) and is used to treat adults and children 2.5 years and older who do not make enough growth hormone.
Important Safety Information
Do not use Sogroya® if:
- you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
- you have cancer or other tumors
- you are allergic to somapacitan-beco or any of the ingredients in Sogroya®
- your healthcare provider tells you that you have certain types of eye problems caused by diabetes
- you are a child with closed bone growth plates
- you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)
Before taking Sogroya®, tell your healthcare provider about all of your medical conditions, including if you:
- have had heart or stomach surgery, trauma, or serious breathing problems
- have had cancer or any tumor
- have diabetes
- have adrenal gland problems
- are taking replacement therapy with glucocorticoids
- have thyroid gland problems
- have liver problems
- are a child with a history of worsening of curvature of the spine (scoliosis)
- are pregnant or plan to become pregnant. It is not known if Sogroya® will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant
- are breastfeeding or plan to breastfeed. It is not known if Sogroya® passes into your breast milk. You and your healthcare provider should decide if you will take Sogroya® while you breastfeed
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Sogroya® may affect the way some medicines work, and some medicines may affect how Sogroya® works.
How should I use Sogroya®?
- Use Sogroya® exactly as your healthcare provider tells you to
- Use Sogroya® 1 time each week
- If you miss a dose of Sogroya®, the missed dose can be taken within 3 days (72 hours) after the scheduled dosing day. One-time weekly dosing for the next dose can be started again on the regularly scheduled dosing day
- If more than 3 days (72 hours) have passed, skip the missed dose, and take your next dose on the regularly scheduled dosing day
- Sogroya® pens are for use by 1 person only
- Do not share your Sogroya® pens and needles with another person, even if the needle has been changed. You may give another person an infection or get an infection from them
What are the possible side effects of Sogroya®?
Sogroya® may cause serious side effects, including:
- high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma, or serious breathing problems
- increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. You or your child’s healthcare provider will need to monitor you or your child for a return of cancer or a tumor. Contact the healthcare provider if you or your child start to have sudden changes in behavior, headaches, vision problems, or changes in moles, birthmarks, or the color of your or your child’s skin
- new or worsening high blood sugar or diabetes. You or your child’s blood sugar may need to be monitored during treatment with Sogroya®
- increase in pressure in the skull. If you or your child have headaches, eye problems, nausea or vomiting, contact the healthcare provider
- serious allergic reactions. Get medical help right away if you or your child have the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness, or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, sweating
- your or your child’s body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your or your child’s joints or muscles or nerve problems that cause pain, burning or tingling in the hands, arms, legs, and feet. Tell your or your child’s healthcare provider if you or your child have any of these signs or symptoms of fluid retention
- decrease in a hormone called cortisol. The healthcare provider will do blood tests to check your or your child’s cortisol levels. Tell your or your child’s healthcare provider if you or your child have darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
- decrease in thyroid hormone levels. Decreased thyroid hormone levels may affect how well Sogroya® works. The healthcare provider will do blood tests to check you or your child’s thyroid hormone levels
- severe and constant abdominal pain. This could be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
- loss of fat and tissue weakness in the area of skin you or your child inject. Talk to your or your child’s healthcare provider about rotating the areas where you or your child inject Sogroya®
- worsening of curvature of the spine in children (scoliosis)
- hip and knee pain or a limp in children (slipped capital femoral epiphysis)
- high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems, including sleep apnea
- increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood. You or your child’s healthcare provider will do blood tests to check this
The most common side effects of Sogroya® in children include: common cold, headache, fever, pain in extremity, and reaction to injection
The most common side effects of Sogroya® in adults include: back pain, joint pain, indigestion, sleep problems, dizziness, swelling of the tonsils (tonsillitis), vomiting, high blood pressure, increase in the level of an enzyme in your blood called creatine phosphokinase, weight gain, and low red blood cells (anemia)
Please click here for Sogroya® Prescribing Information.
Sogroya® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Important Safety Information
Do not use Sogroya® if:
- you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
- you have cancer or other tumors
- you are allergic to somapacitan-beco or any of the ingredients in Sogroya®
- your healthcare provider tells you that you have certain types of eye problems caused by diabetes
- you are a child with closed bone growth plates
- you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)
What is Sogroya®?
- Sogroya® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body.
- It is given by injection under the skin (subcutaneous) and is used to treat adults and children 2.5 years and older who do not make enough growth hormone.
Important Safety Information
Do not use Sogroya® if:
- you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
- you have cancer or other tumors
- you are allergic to somapacitan-beco or any of the ingredients in Sogroya®
- your healthcare provider tells you that you have certain types of eye problems caused by diabetes
- you are a child with closed bone growth plates
- you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)
Before taking Sogroya®, tell your healthcare provider about all of your medical conditions, including if you:
- have had heart or stomach surgery, trauma, or serious breathing problems
- have had cancer or any tumor
- have diabetes
- have adrenal gland problems
- are taking replacement therapy with glucocorticoids
- have thyroid gland problems
- have liver problems
- are a child with a history of worsening of curvature of the spine (scoliosis)
- are pregnant or plan to become pregnant. It is not known if Sogroya® will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant
- are breastfeeding or plan to breastfeed. It is not known if Sogroya® passes into your breast milk. You and your healthcare provider should decide if you will take Sogroya® while you breastfeed
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Sogroya® may affect the way some medicines work, and some medicines may affect how Sogroya® works.
How should I use Sogroya®?
- Use Sogroya® exactly as your healthcare provider tells you to
- Use Sogroya® 1 time each week
- If you miss a dose of Sogroya®, the missed dose can be taken within 3 days (72 hours) after the scheduled dosing day. One-time weekly dosing for the next dose can be started again on the regularly scheduled dosing day
- If more than 3 days (72 hours) have passed, skip the missed dose, and take your next dose on the regularly scheduled dosing day
- Sogroya® pens are for use by 1 person only
- Do not share your Sogroya® pens and needles with another person, even if the needle has been changed. You may give another person an infection or get an infection from them
What are the possible side effects of Sogroya®?
Sogroya® may cause serious side effects, including:
- high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma, or serious breathing problems
- increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. You or your child’s healthcare provider will need to monitor you or your child for a return of cancer or a tumor. Contact the healthcare provider if you or your child start to have sudden changes in behavior, headaches, vision problems, or changes in moles, birthmarks, or the color of your or your child’s skin
- new or worsening high blood sugar or diabetes. You or your child’s blood sugar may need to be monitored during treatment with Sogroya®
- increase in pressure in the skull. If you or your child have headaches, eye problems, nausea or vomiting, contact the healthcare provider
- serious allergic reactions. Get medical help right away if you or your child have the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness, or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, sweating
- your or your child’s body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your or your child’s joints or muscles or nerve problems that cause pain, burning or tingling in the hands, arms, legs, and feet. Tell your or your child’s healthcare provider if you or your child have any of these signs or symptoms of fluid retention
- decrease in a hormone called cortisol. The healthcare provider will do blood tests to check your or your child’s cortisol levels. Tell your or your child’s healthcare provider if you or your child have darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
- decrease in thyroid hormone levels. Decreased thyroid hormone levels may affect how well Sogroya® works. The healthcare provider will do blood tests to check you or your child’s thyroid hormone levels
- severe and constant abdominal pain. This could be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
- loss of fat and tissue weakness in the area of skin you or your child inject. Talk to your or your child’s healthcare provider about rotating the areas where you or your child inject Sogroya®
- worsening of curvature of the spine in children (scoliosis)
- hip and knee pain or a limp in children (slipped capital femoral epiphysis)
- high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems, including sleep apnea
- increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood. You or your child’s healthcare provider will do blood tests to check this
The most common side effects of Sogroya® in children include: common cold, headache, fever, pain in extremity, and reaction to injection
The most common side effects of Sogroya® in adults include: back pain, joint pain, indigestion, sleep problems, dizziness, swelling of the tonsils (tonsillitis), vomiting, high blood pressure, increase in the level of an enzyme in your blood called creatine phosphokinase, weight gain, and low red blood cells (anemia)
Please click here for Sogroya® Prescribing Information.
Sogroya® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.